- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.14 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DU: 2'-DEOXYURIDINE-5'-MONOPHOSPHATE(Non-covalent)
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
FDA.2: 21 residues within 4Å:- Chain A: R.90, H.91, R.92, I.93, N.181, L.185, K.186, H.190, A.191
- Chain C: T.67, E.70, I.93, N.175, R.177
- Chain D: A.94, S.95, N.97, E.98, S.100
- Ligands: FDA.5, DU.8
19 PLIP interactions:4 interactions with chain C, 12 interactions with chain A, 3 interactions with chain D- Hydrogen bonds: C:N.175, C:R.177, A:R.90, A:R.90, A:R.92, A:R.92, A:I.93, A:N.181, A:N.181, D:S.95, D:E.98, D:E.98
- Salt bridges: C:R.177, A:H.91, A:H.91, A:R.92, A:R.92
- pi-Stacking: C:H.65
- Hydrophobic interactions: A:L.185
FDA.4: 20 residues within 4Å:- Chain B: R.90, H.91, R.92, I.93, N.181, L.185, H.190, A.191
- Chain C: A.94, S.95, N.97, E.98, S.100
- Chain D: T.67, E.70, I.93, N.175, R.177
- Ligands: DU.6, FDA.7
20 PLIP interactions:13 interactions with chain B, 3 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: B:L.185, B:H.190
- Hydrogen bonds: B:R.90, B:R.90, B:R.92, B:I.93, B:N.181, B:N.181, B:K.186, C:S.95, C:E.98, C:E.98, D:T.67, D:N.175, D:R.177
- Salt bridges: B:H.91, B:H.91, B:R.92, B:R.92, D:R.177
FDA.5: 22 residues within 4Å:- Chain A: S.42, T.67, E.70, I.93, N.175, R.177
- Chain B: S.95, N.97, E.98, S.100, R.102, Y.103
- Chain C: R.90, H.91, R.92, I.93, N.181, L.185, H.190, A.191
- Ligands: FDA.2, DU.3
20 PLIP interactions:12 interactions with chain C, 3 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: C:L.185
- Hydrogen bonds: C:R.90, C:R.90, C:R.92, C:R.92, C:I.93, C:N.181, C:N.181, B:S.95, B:E.98, B:E.98, A:N.175, A:R.177, A:R.177
- Salt bridges: C:H.91, C:H.91, C:R.92, C:R.92, A:R.177
- pi-Cation interactions: A:H.65
FDA.7: 23 residues within 4Å:- Chain A: A.94, S.95, N.97, E.98, S.100, R.102, Y.103
- Chain B: S.42, T.67, E.70, I.93, N.175, R.177
- Chain D: R.90, H.91, R.92, I.93, N.181, L.185, H.190, A.191
- Ligands: DU.1, FDA.4
21 PLIP interactions:14 interactions with chain D, 4 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: D:L.185, D:H.190
- Hydrogen bonds: D:R.90, D:R.90, D:R.92, D:R.92, D:I.93, D:N.181, D:N.181, D:K.186, B:N.175, B:R.177, B:R.177, A:S.95, A:E.98, A:E.98
- Salt bridges: D:H.91, D:H.91, D:R.92, D:R.92, B:R.177
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mathews, I.I., Flavin-Dependent Thymidylate Synthase as a Drug Target for Deadly Microbes: Mutational Study and a Strategy for Inhibitor Design. J Bioterror Biodef (2013)
- Release Date
- 2014-03-26
- Peptides
- Thymidylate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.14 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x DU: 2'-DEOXYURIDINE-5'-MONOPHOSPHATE(Non-covalent)
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mathews, I.I., Flavin-Dependent Thymidylate Synthase as a Drug Target for Deadly Microbes: Mutational Study and a Strategy for Inhibitor Design. J Bioterror Biodef (2013)
- Release Date
- 2014-03-26
- Peptides
- Thymidylate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D